Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Apr 05, 2024 $14.06 $14.24 $13.62 $13.74 1 372 605
Apr 04, 2024 $14.60 $14.79 $14.22 $14.29 1 007 768
Apr 03, 2024 $14.08 $14.78 $14.00 $14.42 1 347 858
Apr 02, 2024 $15.12 $15.15 $14.07 $14.39 1 339 848
Apr 01, 2024 $15.63 $15.63 $14.98 $15.49 1 281 660
Mar 28, 2024 $14.55 $16.05 $14.38 $15.63 2 403 276
Mar 27, 2024 $14.78 $15.49 $12.92 $14.64 11 917 120
Mar 26, 2024 $13.43 $13.57 $13.04 $13.07 1 056 878
Mar 25, 2024 $13.19 $13.60 $12.90 $13.20 1 360 196
Mar 22, 2024 $13.74 $13.95 $13.08 $13.21 734 347
Mar 21, 2024 $13.77 $14.04 $13.55 $13.95 843 231
Mar 20, 2024 $13.40 $13.85 $13.26 $13.63 885 833
Mar 19, 2024 $13.84 $13.97 $13.46 $13.54 1 037 373
Mar 18, 2024 $14.05 $14.32 $13.81 $13.82 884 237
Mar 15, 2024 $14.48 $14.66 $13.91 $13.98 1 110 667
Mar 14, 2024 $14.84 $14.94 $14.45 $14.61 811 321
Mar 13, 2024 $15.24 $15.74 $14.75 $14.82 672 866
Mar 12, 2024 $15.90 $15.90 $14.93 $15.29 1 008 810
Mar 11, 2024 $16.72 $16.89 $15.87 $15.99 1 121 364
Mar 08, 2024 $17.44 $18.04 $16.52 $16.54 1 042 141
Mar 07, 2024 $16.75 $17.40 $16.65 $17.29 785 524
Mar 06, 2024 $16.37 $16.74 $16.35 $16.65 518 784
Mar 05, 2024 $16.22 $16.58 $16.06 $16.30 544 029
Mar 04, 2024 $16.26 $16.58 $15.88 $16.43 699 063
Mar 01, 2024 $15.35 $16.31 $15.19 $16.25 903 162
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT